Wed, Aug 25, 2010 -- 9:00 AM
Labs in Limbo
National Institutes of Health director Francis Collins said Tuesday that the recent court ruling blocking federally funded research on human embryonic stem cells won't affect grant payments that have already been paid out this year. But the institute will freeze its reviews of new grants of this type. Although California's $3 billion stem cell initiative is not affected, we talk about the ruling and its potential impact on Bay Area biotech.
Host: Michael Krasny
Guests:
- Art Torres, former chairman of the California Democratic Party and vice chair for the board at California Institute for Regenerative Medicine
- Dr. David Stevens, chief executive officer of Christian Medical and Dental Associations
- Dr. Helen Blau, professor and director of Baxter Laboratory for Stem Cell Biology at Stanford University
- Tom Abate, staff writer covering economics for San Francisco Chronicle
Please ensure that all comments adhere to our community guidelines. We reserve the right to edit or remove comments that do not follow these guidelines.
Also, please note that your comments could be read on air. We may edit them for clarity or brevity, and we will use only your first name to identify you on the air.
Also, please note that your comments could be read on air. We may edit them for clarity or brevity, and we will use only your first name to identify you on the air.


